Pharmaceutical composition and health functional food for preventing, ameliorating or treating thrombosis containing extract of vespa velutina nigrithorax as active ingredient
Abstract
An antithrombotic composition containing an extract of Vespa velutina nigrithorax as an active ingredient, and more particularly, a pharmaceutical composition and a health functional food for preventing, ameliorating or treating thrombosis by inhibition of blood coagulation and inhibition of platelet aggregation, which contain an ethyl acetate fraction of an extract of Vespa velutina nigrithorax as an active ingredient. The extract exhibits antithrombotic activity by inhibiting platelet aggregation while exhibiting strong anticoagulant activity by inhibiting thrombosis-related enzymes and blood clotting factors. Also, the extract has no human erythrocyte hemolytic activity, has excellent heat stability, and the thrombosis-related enzyme and blood clotting factor inhibitory effects thereof are not lost even under an acidic condition of pH 2 and in plasma.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A pharmaceutical composition for preventing or treating thrombosis containing an extract of Vespa velutina nigrithorax as an active ingredient.
2 . The pharmaceutical composition of claim 1 , wherein the extract is an ethanol extract.
3 . The pharmaceutical composition of claim 1 , wherein the extract is an ethyl acetate fraction obtained after ethanol extraction.
4 . A health functional food for preventing or ameliorating thrombosis containing an extract of Vespa velutina nigrithorax as an active ingredient.
5 . The health functional food of claim 4 , wherein the extract is an ethanol extract.
6 . The health functional food of claim 4 , wherein the extract is an ethyl acetate fraction obtained after ethanol extraction.Join the waitlist — get patent alerts
Track US2023038188A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.